<b>Gapping up <br/>In reaction to strong earnings/guidance</b>:<br/>HIIQ +39%, ALDX +27.6%, FH +17.1%, (also FORM Holdings to acquire 100% of XpresSpa through a private placement of its common stock to Mistral Equity Parterns and other existing XpresSpa holders at $2.31/share or $1.73 mln), REN +12.7%, WAC +11.8%, ENDP +11%, CSLT +10.6%, WPRT +10.1%<br/>AMPH +9.4%, VSLR +8.8%, CASC +8.3%, NVRO +7.5%, GIGA +6.5%, (also receives a $1.9 mln order for non-recurring engineering services associated with its Microsource business unit from an aerospace company), KNDI +6.5%, ATSG +6.3%, ATSG +6.3%, EGY +6.2%, EGY +6.2%, MIME +5.9%, HEAR +5.5%, (thinly traded), AMAG +5.4%, MCHP +5.3%, (also increased quarterly cash dividend to $0.36/share from $0.3595/share), LGIH +5.2%, BDSI +5%<br/>CPE +4.7%, OPK +4.3%, IDI +4.1%, (also annouces Harry Jordan as COO), SIEN +4.1%, EGRX +3.9%, NILE +3.8%, WBMD +3.5%, WBMD +3.5%, INCY +3.5%, ZBRA +3.5%, MSTX +3.5%, ZLTQ +3.3%, FGEN +3.2%, OCUL +3.1%, AMID +3%<br/>DQ +2.7%, IONS +2.6%, RSPP +2.4%, CECE +2.2%, IPHI +2%, IFF +1.7%, TWLO +1.5%, ELNK +1.3%, CLVS +1.3%, FSC +1.2%, EXC +1.1%, FSM +1%<br/>M&A news: MWW +22.4% (to be acquired by Randstad Holding (RANJY) for $3.40 per share; also reported earnings), . <br/><br/><b>Other news:</b><br/>ALDX +27.2% (reports 'positive' data from a clinical trial of NS2)<br/>MESO +16.6% (thinly traded - Phase 2 trial results of Mesoblast's cell therapy show dose-related improvements in biologic refractory rheumatoid arthritis)<br/>SPEX +14.9% (enters into a non-binding letter of intent to invest in DatChat in exchange for an equity security interest in DatChat)<br/>VRX +6.4% (announces relaunch of generic Ofloxacin Otic solution, also reported earnings)<br/>WPZ +4.7% (Williams and Williams Partners announced they have agreed to sell the companies' Canadian businesses to Inter Pipeline Ltd. for combined cash proceeds of $1.35 billion CAD)<br/>CPS +3.9% (S&P announces Cooper-Standard Holdings will replace QLogic Corp. (QLGC) in the S&P SmallCap 600 after the close of trading on Wednesday August 10<br/>PSTI +2.6% (announces that its critical limb ischemia program in the EU has been awarded an $8 mln grant)<br/>AAL +2.6% (reports July and year-to-date 2016 traffic results)<br/>NVO +1.7% (still checking)<br/>BSX +0.5% (receives FDA approval for the EMBLEM MRI Subcutaneous Implantable Defibrillator System)<br/><b>Analyst comments:</b><br/>VALE +0.8% (upgraded to Equal Weight from Underweight at Morgan Stanley)<br/>CVX +0.6% (upgraded to Overweight from Neutral at Piper Jaffray)<br/><b>Gapping down<br/>In reaction to disappointing earnings/guidance:</b><br/>CNXR -35%, DRYS -29%, IPXL -26.4%, TUBE -23.1%, MODN -20.1%, MXL -15.1%, W -14.9%, FSTR -14.7%, CAS -11.6%, CMT -10%, HRI -9.7%, MTW -9.3%, ROG -8.9%, NCLH -8.2%<br/>VTTI -8%, (also VTTI Energy Partners to acquire an additional 8.4% equity interest in VTTI MLP B.V. and associated pro-rata net debt from VTTI MLP Partners B.V. for cash consideration of $96.2 mln; commences 5.25 mln public offering of common units representing limited partner interests in the Partnership )<br/>NPTN -6.7%, RRGB -5%, (also announces that Denny Marie Post has been appointed as CEO and to the board, effective August 8 2016 ), BOJA -4.8%, GPS -4%, (Gap reports July same store sales -4.0% vs -3.6% Retail Metrics consensus and issues Q2 guidance)<br/>EVEP -3.8%, NEWT -3.3%, SNI -3.3%, JPEP -3.1%, LC -3.1%, (also CFO Dolan stepping down), MNKD -3%, KITE -3%, AER -2.8%, ARLZ -2.8%, USFD -2.6%,<br/>COH -2.3%, NUAN -2%, DVA -1.8%, ARNA -1.8%, HTZ -1.7%, FNV -1.1%<br/><b>Other news:</b><br/>TWER -19.4% ( files for $20 mln common stock offering )<br/>FCSC -19.4% ( to offer and sell shares of its common stock and related warrants to purchase shares of its common stock in an underwritten public offering)<br/>ARRY -11.2% (Array's partner AstraZeneca provides update on Phase III trial of Selumetinib in non-small cell lung cancer; study did not meet its primary end point)<br/>IAG -8.6% (IAMGOLD to sell, on a bought deal basis, 38.85 mln common shares at a price of $5.15/share, for aggregate gross proceeds of ~$200 mln; commences cash tender offer for up to $150 million of its 6.75% Senior Notes due 2020)<br/>VTTI -7.9% (prices 5.25 mln common units representing limited partner interests in the Partnership for total gross proceeds of ~ $101.3 mln or ~$19.30/share), FOXF -6.2% (Fox Factory Holding announces that an existing stockholders intends to offer for sale an aggregate of 3.5 mln shares of the Co's common stock in underwritten secondary offering )<br/>PSXP -5% ( announces an underwritten public offering of 6 mln common units )<br/>ACAD -4.2% ( to offer and sell $200 mln of its common stock in an underwritten public offering )<br/>X -3.8% ( commences 17 mln common stock offering)<br/>BGS -3.7% (prices 3.75 mln common stock offering at $49.00/share)<br/>TSE -3% (Trinseo announces that Bain Capital Everest Manager Holding has agreed to sell 8 mln ordinary shares pursuant to its shelf registration statement)<br/>BMRN -3% (files mixed securities shelf offering; commences 7.5 mln common stock offering)<br/>WING -2.6% (announces that a stockholder, namely an affiliate of Roark Capital, intends to offer for sale in an underwritten secondary offering 6 mln shares of the co's common stock )<br/>AZN -1.1% (provides update on Phase III trial of Selumetinib in non-small cell lung cancer; study did not meet its primary end point)<br/>AKR -1% ( announces sale of 4.2 mln common shares )<br/>SAVE -0.8% (reports July prelim traffic; RPMs +18.4% Y/Y on ASMs +17.1% Y/Y, load factor for July 2016 was 89.8%, +1%)<br/><b>Analyst comments:</b> AV -1.4% (downgraded to Neutral from Outperform at Macquarie)<br/><br/>Briefing.com<br/>